Skip to main content
. 2017 Jan 19;7(1):e011213. doi: 10.1136/bmjopen-2016-011213

Table 4.

Univariable and multivariable associations between a positive decision to order a CA and factors using Generalised Linear Mixed Models (GLMM)

Factor GROUP 1 (n=57 cardiologists)
GROUP 2 (n=54 cardiologists)
Univariable analysis
Multivariable analysis
Univariable analysis
Multivariable analysis
Raw % CA=yes‡ OR 95% CI LL-UL OR 95% CI LL–UL p Value* Raw % CA=yes‡ OR 95% CI LL–UL OR 95% CI LL–UL p Value*
Troponin levels
  Elevated 80.6 13.7 8.25  to 22.69 66.90 26.29 to 170.25 ≤0.001 84.9 11.57 7.14 to 18.76 55.80 22.50 to 138.36 ≤0.001
  Normal 26.9 1.0 1.0 33.9 1.0 1.0
ECG changes† ≤0.001 ≤0.001
 Aspecific 43.0 1.04 0.66  to 1.65 1.13 0.54 to 2.39 0.74 49.3 1.13 0.71 to 1.82 2.00 0.88 to 4.56 0.10
 Typical ischaemic 74.7 4.17 2.51 to 6.92 15.39 6.37 to 37.17 0.001 77.7 4.05 2.41 to 6.79 16.40 4.80 to 56.05 0.001
 Normal 42.8 1.0 1.0 46.4 1.0 1.0
Age† ≤0.001 0.50
 70–80 years 65.0 1.81 1.13 to 2.89 1.21 0.58 to 2.49 0.61 72.8 2.58 1.56 to 4.26 1.08 0.28 to 4.18 0.91
 >80 years 42.0 0.72 0.45 to 1.14 0.14 0.05 to 0.34 0.001 49.7 0.97 0.60 to 1.55 0.58 0.10 to 3.48 0.55
 <70 years 51.7 1.0 1.0 51.4 1.0 1.0
Presence of risk factors† 0.43 0.45
 1 risk factor 51.0 1.01 0.64 to 1.61 0.82 0.35 to 1.91 0.65 59.3 1.07 0.66 to 1.74 0.69 0.30 to 1.59 0.38
 >1 risk factor 58.2 1.40 0.88 to 2.22 1.32 0.61 to 2.85 0.48 59.0 1.08 0.68 to 1.72 1.09 0.50 to 2.39 0.83
 No risk factors 49.7 1.0 1.0 56.0 1.0 1.0
Renal dysfunction† ≤0.001 ≤0.001
 Mild to moderate 54.1 0.62 0.38 to 0.99 0.52 0.23 to 1.18 0.12 64.3 1.36 0.84 to 2.21 2.17 0.84 to 5.60 0.11
 Severe 39.4 0.33 0.21 to 0.54 0.09 0.04 to 0.21 0.001 51.4 0.76 0.47 to 1.21 0.25 0.10 to 0.63 0.001
 No 66.0 1.0 1.0 58.7 1.0 1.0
Previous CAD
 Yes 61.4 2.08 1.42 to 3.04 2.80 1.45 to 5.42 ≤0.01 57.3 0.93 0.63 to 1.37 0.94 0.50 to 1.78 0.75
 No 44.1 1.0 1.0 59.0 1.0 1.0
Persistent chest pain
 Yes 63.2 2.29 1.57 to 3.36 4.90 2.36 to 10.16 0.000 68.4 2.36 1.56 to 3.51 3.79 1.92 to 7.51 0.000
 No 43.6 1.0 1.0 48.2 1.0 1.0
Risk score outcome† NA 0.02
Intermediate NA NA NA NA NA 63.7 4.41 2.60 to 7.49 4.40 0.84 to 22.93 0.08
High NA. NA NA NA NA 71.8 6.32 3.21 to 12.42 1.27 0.09 to 18.20 0.86
Low NA NA NA NA NA 32.7 1.0 1.0

Associations comparing level 2 vs 3 for the different factors were.

▪ ECG changes: typical ischaemic versus aspecific (GROUP 1: p 0.000, OR 13.57, CI 95% 5.65 to 32.60)/(GROUP 2: p 0.000, OR 8.20, CI 95% 2.87 to 23.46).

▪ Age: >80 years versus 70–80 years (GROUP 1: p 0.000, OR 0.11, CI 95% 0.05 to 0.27)/(GROUP 2: p 0.25, OR 0.53, CI 95% 0.18 to 1.55).

▪ Presence of risk factors: >1 risk factor versus 1 risk factor (GROUP 1: p 0.21, OR 1.61, CI 95% 0.77 to 3.36)/(GROUP 2: p 0.22, OR 1.56, CI 95% 0.76 to 3.32).

▪ Renal dysfunction: severe versus mild to moderate (GROUP 1: p 0.000, OR 0.17, CI 95% 0.07 to 0.39)/(GROUP 2: p 0.000, OR 0.12, CI 95% 0.05 to 0.26).

▪ Risk score outcome: high versus intermediate (GROUP 2: p 0.14, OR 0.29, CI 95% 0.06 to 1.50).

*Significance tests for independent factors were based on the loglikelihood ratio test (in bold).

†Significance tests for independent factors with three levels of pairwise comparisons, that is, level 1 vs 2, level 1 vs 3, and level 2 vs 3, were based on the Wald test (in italic).

‡ Raw percentages of patients receiving CA for each level of a factor are presented. Eg, in group 1, for factor Troponin, 222 vignettes are in the category ‘elevated’ and 179 of these received CA, leading to 179/222×100=80.6%.

CAD, coronary artery disease; LL, lower limit; LRT, loglikelihood ratio test; NA, not applicable; UL, upper limit.